Paul Rosen interviews Richard Packard about his early experience of phaco. Dr Packard talks about working with Eric Arnott at the Charing Cross Hospital in London,UK, the first phaco machines, the opposition he encountered from many of his colleagues and the eventual acceptance of the procedure.
Paul Rosen interviews Patrick Condon about the early days of phacoemulsification. Irish surgeon Patrick Condon visited Charles Kelman in New York, where he observed surgeries and travelled with Kelman by private helicopter, as well as later bringing him to Ireland in the mid-1980s. He also worked with Eric Arnott in London, where he learned the […]
Sean Henahan talks to Sathish Srinivasan about the pupillary and visual axis debate and the current consensus among ophthalmologists regarding the correct terminology to be used.
Béatrice Cochener talks to Walter Sekundo about some of the first results with SMILE in the treatment of hyperopia and astigmatism.
Sean Henahan talks to Dr Jenny Yu, Vice Chair of Clinical Operations for the Department of Ophthalmology, University of Pittsburgh Eye Center about complications when dealing with the orbit, facial structures, and the skull base.
Some 50 years after Fyodorov published the first paper on theoretical IOL power calculation, achieving an ideal patient outcome still remains a challenge. Dr Jaime Aramberri talks to Dr Warren Hill, Mesa, Arizona, US about an innovative approach using artificial intelligence, the “Hill-radial basis function”.
Sean Henahan talks to Bekir Sitki Aslan, Head of Eye Department, Ankara Memorial Hospital, Turkey about what has changed 50 years after the introduction of phaco.
Quality of vision following any kind of refractive surgery matters most to patients. But how do we measure this, and how do evaluate the outcomes of various refractive surgical interventions in a comparative way? Marie-José Tassignon discusses this important topic with Dr Ray Applegate, of the University of Houston, Texas.
Sean Henahan talks to José Güell, Associate Professor Ophthalmology, Autonoma University, Barcelona, Spain, about Ocular Surface Disease and the impact it has on surgical outcomes.
A combination of a topical corticosteroid and a nonsteroidal anti-inflammatory drug (NSAID) is more effective than either agent alone in reducing the risk of developing cystoid macular edema (CME) after cataract surgery in non-diabetic patients, according to the results of the ESCRS PREMED European study presented at the XXXV Congress of the ESCRS in Lisbon […]
Despite the improvements in surgical and medical therapy of glaucoma in recent years, maintaining target IOP is still a challenge in many cases. Marie Jose Tassignon talks to Professor Carrol Webers, Head of the University Eye Clinic, Maastricht, The Netherlands about how minimally invasive glaucoma surgery, may help to optimize glaucoma management.
Post-operative progressive endothelial cell loss continues to be a problem following refractive surgery. Dan Epstein speaks with Dr Massimo Busin, Villa Serena Hospital, Forli, Italy about the clinical management of this problem.